THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA
FDA Recall #Z-0567-2022 — Class II — December 10, 2021
Product Description
THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA
Reason for Recall
This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.
Recalling Firm
Mallinckrodt Pharmaceuticals Ireland Ltd — Dublin 15, N/A
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Devices
Product Quantity
3
Distribution
US Nationwide distribution in the states of CA, FL, GA, MA, MI, NC, NJ, NY, OH, TN, TX, VA, WV.
Code Information
Dunnage case consists of a random unknown lot, which may have been shipped in place of Kit lot K341
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medical device immediately and consult your healthcare provider. Contact the recalling firm for instructions on return or replacement. If you experienced an adverse event, inform your doctor.